Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Recently granted patents

New US pharmaceutical patent grants from the past 12 months — competitive surveillance for BD and IP teams.

Patents
890

Quick answer

890 pharmaceutical patents in our USPTO index were granted within the past year. Browse by grant date with links to applicant company portfolios and related drug profiles.

  1. WO 2025232885

    PROCÉDÉ DE PRÉPARATION D'UN AGENT DE DÉGRADATION DE LA TYROSINE KINASE DE BRUTON

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2025230878

    COMPOSÉS MACROCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS DE KRAS ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025230528

    MÉTHODES DE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE

    CALICO LIFE SCIENCES LLC [US] · Granted Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2025230860

    FORMES SOLIDES DE COMPOSÉS MACROCYCLIQUES ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2025230862

    COMPOSÉS AMINÉS MACROCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS DE KRAS ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 2025333394

    Tiparp Inhibitor Compounds

    ABBVIE INC [US] · Granted Thu Oct 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 2025333381

    SOLID STATE FORMS

    AMGEN INC [US] · Granted Thu Oct 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2025224069

    CO-CRISTAUX DE FINÉRÉNONE, DE PECAVAPTAN ET D'INHIBITEURS DE SGLT2

    BAYER AG [DE] · Granted Thu Oct 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. EP 4640274

    LPAR1-INHIBITOREN

    ABBVIE INC [US] · Granted Wed Oct 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2025221754

    UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES

    ABBVIE INC [US] · Granted Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2025219169

    PRÉPARATIONS STABLES EN CAPSULES SOUPLES AVEC REMPLISSAGE LIQUIDE POUR PRINCIPES ACTIFS SENSIBLES À L'HUMIDITÉ

    BAYER CONSUMER CARE AG [CH] · Granted Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 2025325692

    METHODS OF TREATMENT USING ANTI-SEZ6 ANTIBODY DRUG CONJUGATES

    ABBVIE INC [US] · Granted Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2025218772

    FORMES SOLIDES COMPRENANT UN AGENT DE DÉGRADATION DE TYROSINE KINASE DE BRUTON ET LEURS UTILISATIONS

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. WO 2025214466

    CONJUGUÉS DE PYRROLOBENZODIAZÉPINE CIBLÉS

    BEIGENE GUANGZHOU BIOLOGICS MFG CO LTD [CN] · Granted Thu Oct 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2025210141

    SYSTÈME D'ADMINISTRATION UTILE POUR L'ADMINISTRATION TOPIQUE D'ARN

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Thu Oct 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2025211975

    AGONISTES DU RÉCEPTEUR DE L'OREXINE

    BIAL PORTELA & CA SA [PT] · Granted Thu Oct 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2025207959

    ANTICORPS ANTI-RÉCEPTEURS DE LA TRANSFERRINE ET LEURS UTILISATIONS

    BIOGEN MA INC [US] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. WO 2025207099

    INHIBITEURS DE PPAR-DELTA POUR PRÉVENIR UNE FIBRILLATION AURICULAIRE POST-OPÉRATOIRE

    ASTELLAS PHARMA INC [JP] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2025207932

    CAPSIDES DE VAA COMPRENANT DES DOMAINES D'ANTICORPS ANTI-TRANSFERRINE

    BIOGEN MA INC [US] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2025207948

    CAPSIDES D'AAV POUR LE CIBLAGE DU RÉCEPTEUR DE LA TRANSFERRINE HUMAINE

    BIOGEN MA INC [US] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2025201453

    COMPOSÉS MACROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE RAS

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 2025304535

    KAT6 Inhibitors

    BEIGENE SWITZERLAND GMBH [CH] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2025202022

    INHIBITEURS DE L'INTERACTION ENTRE RAS ET SOS1 À BASE DE QUINAZOLINE, MACROCYCLIQUES ET ANTICANCÉREUX

    BAYER AG [DE] · Granted Thu Oct 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 12428487

    Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject

    Dyne Therapeutics, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 12427160

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 12427212

    Nectin-4 binding miniproteins, conjugates and uses thereof

    Aktis Oncology, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 12428415

    Matriptase 2 inhibitors and uses thereof

    Disc Medicine, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 12428376

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 12428416

    ERK inhibitors and uses thereof

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 12428463

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 12428379

    Acylsulfonamide KAT6A inhibitors

    Olema Pharmaceuticals, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 12428395

    Heterocyclic compounds as kinase inhibitor and uses thereof

    SPEROGENIX THERAPEUTICS LIMITED · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 12427155

    Treatment for tau-related diseases

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 12427170

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 12427137

    Method for reducing methane production in animal stomach

    China Agricultural University · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 12428403

    N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 12427132

    Method of improving sleep

    VANDA PHARMACEUTICALS INC. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 12427197

    Methods of producing cobalt nanoparticles and hollow metal nanospheres

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 12427151

    Compositions and method of treating cancer

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 12428432

    Thienopyrimidine derivatives having stereo configurations and use thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 12428489

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 12427148

    Cancer treatment targeted to tumor adaptive responses to protein synthesis stress

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 12428408

    Fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 12427111

    Lipid nanoparticles

    CodeBridgeBio Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 12427199

    Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments

    RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 12427171

    Krill oil composition enriched in LPC-DHA and LPC-EPA

    Aker BioMarine Human Ingredients AS · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 12427125

    Method for treating SARS and treating or preventing ARDS

    Aardvark Therapeutics, Inc. · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 12428455

    Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells

    The Regents of the University of California · Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How recent are these patent grants?

This hub lists published patents with a grant date within the last 365 days, ordered newest first.

Which patent classes are included?

We index USPTO PatentsView records with pharmaceutical CPC classifications A61K and A61P linked to tracked assignee companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.